Board members

Steven Joniau

Ass. Prof. Steven Joniau, MD, PhD

Consultant Urologist

Dept of Urology
University Hospitals Leuven
Herestraat 49
3000 Leuven

Belgium

steven.joniau@uzleuven.be
+32 16 34 69 45
+32 16 34 69 30

UZ Leuven | campus Gasthuisberg | Herestraat 49 | B – 3000 Leuven | www.uzleuven.be

 

Education and Academic carreer

Steven Joniau graduated in Urology in 2002 at the Catholic University of Leuven. In 2003, he was appointed full-time staff member at the Dept. of Urology, University Hospitals Leuven after a 1-year fellowship at the University Hospital of Wales, Cardiff, UK. In July 2012, he obtained his PhD in Medical Sciences entitled ‘High-risk localized prostate cancer: the role of surgery and the development of clinical outcome prediction models’. In 2013, he was appointed Assistant Professor at the Catholic University of Leuven.

Expertise

His principal field of interest is the management of urological cancers. He is heavily involved in uro-oncological surgery and the multidisciplinary approach of pelvic cancers. He also leads numerous research projects at the University Hospitals Leuven, which focus on lymph node staging in prostate and bladder cancer, multimodality treatment and biomarker development of high-risk prostate cancer, the natural history of premalignant lesions of the prostate, chemoprevention of prostate and bladder cancer, minimally invasive treatment of renal cell cancer and prostate cancer, etc.

Participation in boards and committees

Steven Joniau is scientific secretary of the Belgische Vereniging voor Urologie, he is chairman of the Working Group Oncology of the Belgian Association of Urology, he is past-chairman of the Renal Cell Carcinoma Group of the Young Academic Urologists Working Party of the European Association of Urology (EAU), he is member of the EAU Guideline Panel on Prostate Cancer and the SIOG (International Society of Geriatric Oncology) Prostate Cancer Guideline Panel.

He is a member of several international scientific societies: EAU, ASCO (American Society of Clinical Oncology),  SIU (Société Internationale d’Urologie), SIOG and the European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group (EORTC GUCG).

He is appointed Associate Editor of ‘The Journal of OncoPathology’. He is Editorial Advisory Board member of ‘The European Journal of Surgical oncology’, Editorial Board member of ‘The Open Prostate Cancer Journal’, ‘Archivo Italiano di Urologia e Andrologia’, ‘The Central European Journal of Urology’  and  International Scientific Board member of ‘Archivos Españoles de Urología’.

International recognition

Steven Joniau has received several international awards, of which the First prize of the Urological Challenge Session, received at the 2010 European Urology Forum in Davos, Switzerland, the Crystal Matula Award 2011, received at the 2011 EAU annual congress in Vienna, Austria and  the biannual Orion International Oncology Award 2011, received at the 2011 EAU annual congress in Vienna, Austria are the most prestigious.

In the last 10 years, he has published >190 papers in peer-reviewed journals in the field of uro-oncology and minimally invasive surgery. In 2014, he received the Prize for the Best Paper published on Clinical Research in the Urological Literature at the EAU annual congress in Stockholm. He authored several book chapters, he has been invited Faculty in over 100 international congresses and is a faculty member of the ESU (European School of Urology).

Gert De Meerleer

Prof. dr. Gert De Meerleer

Since February 2016, Gert De Meerleer is head-of-clinics at the department of Radiotherapy and Experimental Cancer Research at UZ Leuven. His field of interest is urologic oncology with a focus on implementing modern radiation technology in the treatment of prostate cancer, kidney cancer and to a lesser extent, bladder cancer. He has pioneered on the implementation of stereotactic body radiotherapy in the treatment of oligometastatic prostate cancer. This had lead to a paradigm shift in the treatment of these patients.

Gert De Meerleer successfully defended his Ph.D. in 2000. In this Ph.D., he described the implementation of intensity-modulated radiotherapy in the treatment of prostate cancer. Since then, he (co-)promoted several other Ph.D.’s, most of them dealing with the implementation of intensity-modulated radiotherapy (including arc therapy) in the treatment of urological and, to a lesser extent, gynecologic malignancies. He is active member of the multidisciplinary working group of urological malignancies at Gent University Hospital.

Gert De Meerleer (co-)authored almost 100 A1 publications, most of them in the field of urological oncology and belonging to the highest quartile. He is co-edited several booklets on prostate cancer. He was granted several times and by different organizations (FWO, VLK, Stichting tegen Kanker, …) for his scientific research. He is full professor at Gent University, with a main focus on scientific research in the treatment of urologic malignancies, with a special focus on interaction of stereotactic body radiotherapy and systemic treatments.

Gert De Meerleer is co-president of the Belgian Radiotherapy Awareness and Visibility Organization (BRAVO), is course director of the ESTRO course on target volume delineation and is faculty member of ISSECAM, Oncoforum, Mirrors of Medicine and PROSCA. He has been invited as speaker on most urologic and oncologic congresses. He is involved in teaching at Belgian and European level. He is reviewer for several international cancer organizations and high-ranked journals.

He is married to Louke and is father of Emma and Leontien. In his spare time, he is a dedicated piano player and tries to run from time to time. Good food never disappoints him.

Dr. Lieven Goeman

Birth Date: 06-06-1974, Bruges
Nationality: Belgian
Address : Zwevezelestraat 64, 8810 Lichtervelde, Belgium
Telephone: +32-51237005, +32-486230270
E-mail: LievenGoeman@gmail.com

Professional activities

  • 8/2005 till 7/2006 Staff member, Henri Mondor Hospital, Paris, France under supervision of Prof. Dr. Abbou
  • 8/2006 Staff member in St.- Jan Ziekenhuis, Brussels, for minimal invasive technologies in Urology
  • 8/2012 Staff member AZ Delta Hospital Roeselare, Urology
  • Principal investigator for more than 50 studies in Brussels and Roeselare
  • Consultant of the Department Research and Development in Urology and molecular medicine since 01/2013
  • Coordinator Cluster abdomen since 12/2015 in AZ Delta hospital

Additional medical training and interests

  • 09/2006  Management training EHSAL, Brussels. Thesis: “Is forfaitarisation the future in medicine? A urologic vision. “
  • Education as auditor for JACIE 2012

Scientific activities

  • Interdisciplinary seminar 1995: The role of hypo-proteinemia on the foetal development. Coordinated by Prof. Dr. M. Cokelaere
  • Apprenticeship:
    • Endovascular treatment of the acute non-aneurysmal abdominal aortic thrombosis.
    • Morbid obesity: complications and surgical treatment.
  • Co-scholarship: The physical and antimicrobial effects of microwaves and alcohol preservation on catheters reused for Clean Intermittent Catheterization. Study in cooperation with the department of Microbiology and Materials science and Metallurgy (e.g. Differential Scanning Calorimetry examination).
  • Scientific research in the laboratory of Experimental Immunology since January 2002: Dendritic Cell Tumour vaccination for renal cell carcinoma. In collaboration with the Universities of Nijmeghen, Innsbruck, and Pittsburgh. Supervision Prof. Dr. S. Van Gool and Prof. Dr. H. Van Poppel.
  • Follow-up of the first patients included in a fase II trial for DC vaccination for m-RCC.
  • Reviewer Journal of Endo-Urology since 01/2007
  • Reviewer Urology since 2001
  • Principal investigator for more than 25 studies in Brussels and Roeselare
  • Author of multiple A1 publications and poster prestations

Additional functions

  • NCO Chairman of the ESRU Belgium (European Society of Residents in Urology) since 8/2001 till 8/2005
  • Member of the scientific committee of the ESRU International
  • Board member in the Belgische Vereniging voor Urologie as webmaster since 2005
  • Organiser of the Visiting Professorship Prof. Fisch (Hamburg)  6-9/7/2004, Leuven
  • Organiser of the Visiting Professorship Prof. Rassweiler (Heilbronn)from 30/05 till 01/06/2005, Leuven
  • Reviewer Journal of Endo-Urology since 01/2007
  • Reviewer Urology since 2001
  • Reviewer current opinion in Urology since 2001
  • Chairman working group Quality of Care in Urology since 2011
  • Secretary of the BBVU-APUB
  • President of the BVU
  • Member “ZorgnetVlaanderen” about future of the hospital environment
  • Member working group of Oncology
  • Member VIP2: Quality indicators for prostate cancer treatment

Ass. Prof. dr. Karel Decaestecker

Karel Decaestecker is Head of Clinics at the department of Urology at Ghent University Hospital, Belgium. He is Fellow of the European Board of Urology. He succesfully defended his Ph.D. on Metastasis-directed therapy for oligometastatic prostate cancer recurrence at Ghent University and is appointed as Associate Professor Uro-Oncology at Ghent University since October 1st, 2018.

His main interest is uro-oncology and minimal invasive surgery, especially robot-assisted cystectomy and totally intracorporeal urinary reconstruction. He performed the first robotic kidney transplantation in Belgium in april 2016 and the first robotic renal autotransplantation in Europe in june 2017.

Karel Decaestecker is an active member of several scientific parties, including the EAU Robotic Urology Section (ERUS) Working Group on Robot-assisted Kidney Transplantation (RAKT) and the ERUS Working Group Bladder Cancer. He is board member of the EAU Section of Transplantation Urology (ESTU). He is an expert (proctor) at ORSI Academy for the RAKT course.  He is recently appointed vice-chair of the BVU (Belgische Vereniging voor Urologie). Prof. dr. Decaestecker has written or colaborated in several scientific papers, mainly in the field of uro-oncology, kidney transplantation and minimal invasive surgery. He is highly involved in teaching and training medical students, residents and fellow urologists/surgeons.

Scientific Board members

Dr. Siska Van Bruwaene (AZ Groeninge Kortrijk), Prof. Dr. Valérie Fonteyne (Gent University Hospital), Prof. Dr. Wouter Everaerts (University Hospitals Leuven), Prof. Dr. Geert Villeirs (Gent University Hospital), Christof Vulsteke (AZ Maria Middelares Gent), Dr. Thomas Gevaert (AZ Klina, Antwerpen),  …

Scientific Summits is happy and proud to welcome Dr. Karel Decaestecker (Gent University Hospital) as new board member.